1. Home
  2. TLX vs CHH Comparison

TLX vs CHH Comparison

Compare TLX & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLX
  • CHH
  • Stock Information
  • Founded
  • TLX 2015
  • CHH 1939
  • Country
  • TLX Australia
  • CHH United States
  • Employees
  • TLX N/A
  • CHH N/A
  • Industry
  • TLX Biotechnology: Pharmaceutical Preparations
  • CHH Hotels/Resorts
  • Sector
  • TLX Health Care
  • CHH Consumer Discretionary
  • Exchange
  • TLX Nasdaq
  • CHH Nasdaq
  • Market Cap
  • TLX 6.0B
  • CHH 6.8B
  • IPO Year
  • TLX N/A
  • CHH 1997
  • Fundamental
  • Price
  • TLX $16.71
  • CHH $123.95
  • Analyst Decision
  • TLX Strong Buy
  • CHH Hold
  • Analyst Count
  • TLX 1
  • CHH 14
  • Target Price
  • TLX $22.00
  • CHH $139.07
  • AVG Volume (30 Days)
  • TLX 28.3K
  • CHH 449.4K
  • Earning Date
  • TLX 01-01-0001
  • CHH 05-08-2025
  • Dividend Yield
  • TLX N/A
  • CHH 0.93%
  • EPS Growth
  • TLX 798.14
  • CHH 22.29
  • EPS
  • TLX 0.09
  • CHH 6.20
  • Revenue
  • TLX $484,687,790.00
  • CHH $791,189,000.00
  • Revenue This Year
  • TLX N/A
  • CHH $104.25
  • Revenue Next Year
  • TLX N/A
  • CHH $3.77
  • P/E Ratio
  • TLX $179.17
  • CHH $19.99
  • Revenue Growth
  • TLX 55.85
  • CHH 4.10
  • 52 Week Low
  • TLX $13.61
  • CHH $109.22
  • 52 Week High
  • TLX $30.36
  • CHH $157.86
  • Technical
  • Relative Strength Index (RSI)
  • TLX N/A
  • CHH 41.69
  • Support Level
  • TLX N/A
  • CHH $122.55
  • Resistance Level
  • TLX N/A
  • CHH $129.97
  • Average True Range (ATR)
  • TLX 0.00
  • CHH 5.28
  • MACD
  • TLX 0.00
  • CHH 0.27
  • Stochastic Oscillator
  • TLX 0.00
  • CHH 42.35

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

About CHH Choice Hotels International Inc.

As of Dec. 31, 2023, Choice Hotels operated 633,000 rooms across 15 brands addressing the economy and midscale segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total domestic rooms), while Ascend and Cambria (7% of total domestic rooms) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added around 70,000 rooms. Franchises account for 100% of total revenue, and the United States represent 79% of total rooms in 2023.

Share on Social Networks: